secwatch.observer — SEC 8-K summary
======================================

Issuer:     1606 CORP. (CBDW)
CIK:        0001877461
Form:       8-K
Filed at:   2024-12-18T23:59:59+00:00
Accession:  0001477932-24-008169
Event type: other_material
Sentiment:  positive
Materiality: 0.30
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

1606 Corp. supports Adnexus AI health tech; LOI terminated but still pursuing deal
--------------------------------------------------------------------------------

- 1606 Corp. issued press release supporting Adnexus Biotechnologies' Neural Temporal Fingerprinting AI technology for personalized health monitoring using EEG/ECG.
- Adnexus' technology targets early detection of Alzheimer's, Parkinson's, PTSD, and cardiovascular risks via AI analysis of EEG/ECG signals.
- Previously signed LOI for strategic investment by 1606 in Adnexus terminated on Nov 28, 2024, but parties still working to close the deal.
- CEO Austen Lambrecht sees transformative potential in AI-driven health diagnostics and wearable integration for both companies.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1877461/000147793224008169/0001477932-24-008169-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1877461/000147793224008169/onesix_8k.htm
  HTML page:      https://secwatch.observer/filing/0001477932-24-008169

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer